Baxalta's IP Suit Over Genentech Blood Drug Gets New Life
A Federal Circuit panel revived a patent fight over Genentech Inc.'s blockbuster hemophilia drug Hemlibra on Thursday, after finding that U.S. Circuit Judge Timothy B. Dyk messed up claim construction while overseeing...To view the full article, register now.
Already a subscriber? Click here to view full article